Drugs / cefuroxim
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00261742 | Oct 2005 → Dec 2006 | streptococcal infection | University Children's Hospital Basel | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05750966 | Jul 2023 → Apr 2026 | cholangitis | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04803422 Comparator | Apr 2021 → May 2024 | appendicitis | Zealand University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cefuroxim | “In case of allergy to penicillin: Single-dose inj. Metronidazole and intravenous inj. Cefuroxim.” NCT04803422 ↗ |
| Route | Oral | “oral cefuroxim for 7 days” NCT00261742 ↗ |